investorscraft@gmail.com

Intrinsic ValueCawachi Limited (2664.T)

Previous Close¥3,100.00
Intrinsic Value
Upside potential
Previous Close
¥3,100.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Cawachi Limited operates as a regional drugstore chain in Japan, specializing in pharmaceuticals, health foods, cosmetics, and daily necessities. The company’s revenue model is anchored in retail sales across its 355 stores, supplemented by ancillary services such as insurance. Positioned in the competitive Japanese drugstore sector, Cawachi differentiates itself through a broad product assortment and localized store presence, catering to both urban and suburban demographics. The company’s focus on healthcare essentials provides resilience against economic cycles, though it faces stiff competition from larger national chains and e-commerce players. Its regional concentration in Japan limits geographic diversification but allows for deeper customer relationships and operational efficiency. Cawachi’s integration of insurance services adds a supplementary revenue stream, though pharmaceuticals remain its core driver. The company’s market position is mid-tier, with growth dependent on store expansion and same-store sales improvements in a saturated industry.

Revenue Profitability And Efficiency

Cawachi reported revenue of JPY 287.8 billion for FY2025, with net income of JPY 4.9 billion, reflecting modest profitability in a competitive retail environment. Operating cash flow stood at JPY 7.5 billion, though capital expenditures of JPY 4.3 billion indicate ongoing investments in store operations. The company’s efficiency metrics suggest stable but not exceptional margins, typical for the drugstore sector.

Earnings Power And Capital Efficiency

Diluted EPS of JPY 218.43 underscores Cawachi’s ability to generate earnings despite sector pressures. The company’s capital efficiency is adequate, with operating cash flow covering capex, though reinvestment needs limit free cash flow generation. The low beta of 0.01 indicates minimal earnings volatility, aligning with its defensive business model.

Balance Sheet And Financial Health

Cawachi maintains a solid balance sheet, with JPY 36.7 billion in cash and equivalents against JPY 16.6 billion in total debt, reflecting a conservative leverage profile. The liquidity position supports ongoing operations and potential store expansions, though the debt-to-equity ratio warrants monitoring given the capital-intensive nature of retail.

Growth Trends And Dividend Policy

Growth prospects are tempered by market saturation, with same-store sales and selective expansions likely driving top-line improvements. The company’s dividend payout of JPY 80 per share signals a commitment to shareholder returns, though yield remains modest. Future growth may hinge on operational efficiencies and niche market penetration.

Valuation And Market Expectations

With a market cap of JPY 62.5 billion, Cawachi trades at a moderate valuation relative to earnings, reflecting its regional focus and mid-tier market position. Investor expectations appear grounded, with limited premium for growth given sector headwinds.

Strategic Advantages And Outlook

Cawachi’s regional expertise and diversified product mix provide stability, but long-term success depends on navigating competitive pressures and demographic shifts in Japan. Strategic store optimizations and potential digital integration could enhance competitiveness, though near-term growth is likely incremental.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount